These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2859793)

  • 1. Choice of selective versus nonselective beta blockers: implications for exercise training.
    Kelly JG
    Am J Cardiol; 1985 Apr; 55(10):162D-166D. PubMed ID: 2859793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hemodynamic responses to isoproterenol infusion and surgical stress in patients given cardioselective and noncardioselective beta-adrenergic antagonists.
    de Bruijn N; Reves JG; Croughwell N; Knopes K
    Anesth Analg; 1987 Jul; 66(7):637-42. PubMed ID: 2886078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of long-term cardioselective and nonselective beta-receptor blockade on plasma catecholamines during and after physical exercise in hypertensive patients.
    Franz IW; Lohmann FW; Koch G
    J Cardiovasc Pharmacol; 1980; 2(1):35-44. PubMed ID: 6154203
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise performance and beta-blockade.
    Tesch PA
    Sports Med; 1985; 2(6):389-412. PubMed ID: 2866577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of ratings of perceived exertion for exercise prescription in patients receiving beta-blocker therapy.
    Eston R; Connolly D
    Sports Med; 1996 Mar; 21(3):176-90. PubMed ID: 8776008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In support of cardiac chronotropic beta 2 adrenoceptors.
    Brown JE; McLeod AA; Shand DG
    Am J Cardiol; 1986 Apr; 57(12):11F-16F. PubMed ID: 3010692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Do cardioselective beta-antagonists block the cardiac beta-receptor function also in the long run?].
    Yndgaard S; Lippert FK; Berthelsen PG
    Ugeskr Laeger; 1998 Apr; 160(18):2706-9. PubMed ID: 9599555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P; Rost R; Reinke A; Nagel N; Merten U
    Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation on the efficacy and pharmacokinetics of betaxolol (SL 75212), a cardioselective beta-adrenoceptor blocking drug.
    Balnave K; Neill JD; Russell CJ; Harron DW; Leahey WJ; Wilson R; Shanks RG
    Br J Clin Pharmacol; 1981 Feb; 11(2):171-80. PubMed ID: 6111331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
    Adams HR
    J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of intrinsic sympathomimetic activity for beta blockers.
    Jaillon P
    Am J Cardiol; 1990 Sep; 66(9):21C-23C. PubMed ID: 1977302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta blockers and exercise: physiologic and biochemical definitions and new concepts.
    Harrison DC
    Am J Cardiol; 1985 Apr; 55(10):29D-33D. PubMed ID: 2859795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cardiac beta 2-adrenoceptors in man.
    Brown JE; McLeod AA; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):424-8. PubMed ID: 6299641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three Generations of β-blockers: History, Class Differences and Clinical Applicability.
    do Vale GT; Ceron CS; Gonzaga NA; Simplicio JA; Padovan JC
    Curr Hypertens Rev; 2019; 15(1):22-31. PubMed ID: 30227820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?
    Abila B; Wilson JF; Marshall RW; Richens A
    Br J Clin Pharmacol; 1986 Jul; 22(1):104-7. PubMed ID: 2874824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
    Ni Y; Shi G; Wan H
    J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.